Cargando…

Oncogenic Functions of the Cancer-Testis Antigen SSX on the Proliferation, Survival, and Signaling Pathways of Cancer Cells

SSX is a transcription factor with elusive oncogenic functions expressed in a variety of human tumors of epithelial and mesenchymal origin. It has raised substantial interest as a target for cancer therapy since it elicits humoral responses and displays restricted expression to cancer, spermatogonia...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Arcy, Padraig, Maruwge, Wessen, Wolahan, Barry, Ma, Limin, Brodin, Bertha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005730/ https://www.ncbi.nlm.nih.gov/pubmed/24787708 http://dx.doi.org/10.1371/journal.pone.0095136

Ejemplares similares

Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signaling
por: Maruwge, Wessen, et al.
Publicado: (2008)

The SSX Family of Cancer-Testis Antigens as Target Proteins for Tumor Therapy
por: Smith, Heath A., et al.
Publicado: (2010)

Development of a T Cell Receptor Targeting an HLA-A*0201 Restricted Epitope from the Cancer-Testis Antigen SSX2 for Adoptive Immunotherapy of Cancer
por: Abate-Daga, Daniel, et al.
Publicado: (2014)

Oncogenic cancer/testis antigens: prime candidates for immunotherapy
por: Gjerstorff, Morten F., et al.
Publicado: (2015)

SSX expression and function in prostate cancer
por: Bloom, Jordan E, et al.
Publicado: (2013)

Truncated SSX Protein Suppresses Synovial Sarcoma Cell Proliferation by Inhibiting the Localization of SS18-SSX Fusion Protein
por: Yoneda, Yasushi, et al.
Publicado: (2013)

SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth
por: Ma, L, et al.
Publicado: (2014)

Higher Expression Levels of SSX1 and SSX2 in Patients with Colon Cancer: Regulated In Vitro by the Inhibition of Methylation and Histone Deacetylation
por: Alrubie, Turki M., et al.
Publicado: (2023)

The inhibitory effect of KIAA1456 on the proliferation and metastasis of epithelial ovarian cancer through SSX1 and AKT signaling pathway
por: Zhang, Yingfeng, et al.
Publicado: (2023)

The Synovial Sarcoma-Associated SYT-SSX2 Oncogene Antagonizes the Polycomb Complex Protein Bmi1
por: Barco, Roy, et al.
Publicado: (2009)

Phase transition and remodeling complex assembly are important for SS18-SSX oncogenic activity in synovial sarcomas
por: Cheng, Yanli, et al.
Publicado: (2022)

Expression of Cancer/Testis Antigens is Correlated with Improved Survival in Glioblastoma
por: Freitas, Marcelo Roberto Pereira, et al.
Publicado: (2013)

Proteasome-associated deubiquitinases and cancer
por: Mofers, Arjan, et al.
Publicado: (2017)

Genome-wide recruitment to Polycomb-modified chromatin and activity regulation of the synovial sarcoma oncogene SYT-SSX2
por: Garcia, Christina B, et al.
Publicado: (2012)

SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier
por: Tamaki, Sakura, et al.
Publicado: (2015)

Cancer testis antigen and immunotherapy
por: Krishnadas, Deepa Kolaseri, et al.
Publicado: (2013)

Effect of cancer/testis antigen NY-SAR-35 on the proliferation, migration and invasion of cancer cells
por: Song, Myung-Ha, et al.
Publicado: (2017)

SYT-SSX fusion genes and prognosis in synovial sarcoma
por: Mezzelani, A, et al.
Publicado: (2001)

SSX2IP helps the centrosome grow up
por: Leslie, Mitch
Publicado: (2013)

SSX addiction in melanoma propagates tumor growth and metastasis
por: Traynor, Sofie, et al.
Publicado: (2022)

Interaction between Polycomb and SSX Proteins in Pericentromeric Heterochromatin Function and Its Implication in Cancer
por: Johansen, Simone, et al.
Publicado: (2020)

Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer
por: Nin, Dawn Sijin, et al.
Publicado: (2023)

Targeting cancer testis antigens in synovial sarcoma
por: Mitchell, Geoffrey, et al.
Publicado: (2021)

SSX2 regulates focal adhesion but does not drive the epithelial to mesenchymal transition in prostate cancer
por: Bloom, Jordan E., et al.
Publicado: (2016)

Remodeling and destabilization of chromosome 1 pericentromeric heterochromatin by SSX proteins
por: Traynor, Sofie, et al.
Publicado: (2019)

SS18-SSX drives CREB activation in synovial sarcoma
por: Cyra, Magdalene, et al.
Publicado: (2022)

Iron chelators target both proliferating and quiescent cancer cells
por: Fryknäs, Mårten, et al.
Publicado: (2016)

The cancer testis antigen TDRD1 regulates prostate cancer proliferation by associating with snRNP biogenesis machinery
por: Feng, Qin, et al.
Publicado: (2023)

Regulation of TRAIL-Receptor Expression by the Ubiquitin-Proteasome System
por: Sarhan, Dhifaf, et al.
Publicado: (2014)

Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19
por: Clemente, Valentino, et al.
Publicado: (2020)

Pattern of cancer/testis antigen expression in lung cancer patients
por: KIM, YEONG-DAE, et al.
Publicado: (2012)

Cancer testis antigens: A new paradigm for cancer therapy
por: Suri, Anil, et al.
Publicado: (2012)

Cancer/testis antigens (CTAs) expression in resected lung cancer
por: Jin, Shi, et al.
Publicado: (2018)

Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy
por: Zhang, Yujie, et al.
Publicado: (2019)

Inducible expression of cancer-testis antigens in human prostate cancer
por: Heninger, Erika, et al.
Publicado: (2016)

Characterization of Cancer/Testis Antigens as Prognostic Markers of Ovarian Cancer
por: Vlasenkova, Ramilia, et al.
Publicado: (2023)

Engineering Cancer/Testis Antigens With Reversible S-Cationization to Evaluate Antigen Spreading
por: Miyamoto, Ai, et al.
Publicado: (2022)

Cancer-testis antigen expression and immunogenicity in AL amyloidosis
por: Rosenzweig, M A, et al.
Publicado: (2012)

Immunotherapy in Multiple Myeloma Using Cancer-Testis Antigens
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2015)

The Cancer/Testis Antigen CT45A1 Promotes Transcription of Oncogenic Sulfatase-2 Gene in Breast Cancer Cells and Is Sensible Targets for Cancer Therapy
por: Yang, Ping, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_io65shorf1itreebp535lg7saj